Navigation Links
Carnegie Mellon team makes sequestration recommendations
Date:7/23/2009

PITTSBURGHCarbon capture and sequestration (CCS) technology, which captures carbon dioxide from power plants and safely disposes of it deep underground, will not meet its full potential in the United States without new federal regulations that create a uniform regulatory environment.

This is the conclusion of a set of four policy briefs just released by the CSSReg project led by M. Granger Morgan, head of Carnegie Mellon University's Department of Engineering and Public Policy.

"At the moment, there is a patchwork of different rules across the U.S. and a great deal of legal uncertainty," Morgan said. "We need a clear way for CCS projects to obtain the right to inject carbon dioxide into appropriate geological formations and a strategy for safely addressing long-term stewardship once an injection project ends."

Morgan and his colleagues believe that without a safe and cost-effective way to use CCS, as part of a broader strategy for CO2 emissions control, there is no way the country will be able to achieve the reductions in future CO2 emissions that Congress and the Obama administration are now proposing.

The policy briefs, available from http://www.CCSReg.org, describe changes to federal law and agency rules needed to overcome regulatory and legal barriers to large-scale deployment of carbon sequestration.

The CCSReg project is supported by a $1.85-million grant from the New York-based Doris Duke Charitable Foundation (DDCF) with additional support from the National Science Foundation (NSF). In addition to investigators at Carnegie Mellon, the project team involves experts at the University of Minnesota, the Vermont Law School and the Washington, D.C.- based law firm of Van Ness Feldman.

While Morgan and his colleagues argue that a general framework for "performance-based regulation" should be established today, they believe the U.S. must build and gain experience with several commercial-scale facilities before finalizing many
'/>"/>

Contact: Chriss Swaney
swaney@andrew.cmu.edu
412-268-5776
Carnegie Mellon University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Carnegie Mellons Kris Matyjaszewski recieves EPAs Presidential Green Chemistry Challenge Award
2. Carnegie Mellon researchers apply new statistical test
3. Carnegies Donald Brown receives lifetime achievement award from Society for Developmental Biology
4. Carnegies Doug Koshland elected Fellow of the American Academy of Microbiology
5. Carnegies Joe Berry elected Fellow of the American Geophysical Union
6. Carnegies Arthur Grossman receives Gilbert Morgan Smith medal
7. Carnegie Mellon to unveil new sequestration plan
8. Carnegies Field and Koshland Elected AAAS Fellows
9. Carnegie Mellon developing automated systems to enable precision farming of apples, oranges
10. Carnegie Mellons Philip LeDuc participates in think tank forums
11. Carnegie Mellon to receive $900,000 from EPA for brownfields research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...are the bare essentials of life, the indispensable...urvive on its own? Can we describe the molecular a...anism functions as a system? These are just some o...etween the European Molecular Biology Laboratory (...gulacio Genmica (CRG) in Barcelona, Spain, set out...
(Date:11/25/2009)...fficers and ambulance workers faced a terrifying r...ey battled to save people from the collapsing Twin... evacuated as many people as they could in an area...aking their jobs even harder was the problem of po...latives jammed mobile networks with calls and the ...
(Date:11/25/2009)...as vital to your health as what you eat, found res...ies. Their experiments in mice revealed that the d...e liverthe body,s metabolic clearinghouseis mostly...ircadian clock as conventional wisdom had it. , ...ge number of genes completely independent of the c...
Breaking Biology News(10 mins):First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Magic box for mission impossible 2Magic box for mission impossible 3Feeding the clock 2Feeding the clock 3CryoLife to Present at Upcoming Investor Conferences in New York 6166 1CryoLife to Present at Upcoming Investor Conferences in New York 6166 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 6161 1Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 6161 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 6161 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 6161 4Aware Inc Announces Support for New ITU Testing Standard with Line Diagnostics Platform 10688 1Aware Inc Announces Support for New ITU Testing Standard with Line Diagnostics Platform 10688 2Aware Inc Announces Support for New ITU Testing Standard with Line Diagnostics Platform 10688 3Aware Inc Announces Support for New ITU Testing Standard with Line Diagnostics Platform 10688 4
...choanoflagellates have in common? More than you,d ...me shows these ancient organisms have similar leve...s, including humans, use to communicate with each ... in the Proceedings of the National Academies of ...llates, role as an evolutionary link between singl...
...rkinson,s Disease Foundation (PDF) is pleased to a...ternational Research Grants and Fellowship Program...f 19 Parkinson,s scientists, chosen on April 11 fr...c review committee led by Stanley Fahn, M.D., PDF,... awardees, who hail from around the world, include...
...evokes memories of promising spring days and visio...been well-loved staples in America,s yards and gar...ry. , Native to East Asia and Southeast Europe, l...ettlers and were sold in American nurseries as ear...ica may be those at the Governor Wentworth estate ...
Other Biology News:Crossed (evolutionary) signals? 2Crossed (evolutionary) signals? 3The Parkinson's Disease Foundation awards $950,000 in seed grants 2The Parkinson's Disease Foundation awards $950,000 in seed grants 3Patriotic new lilacs introduced 2
(Date:11/27/2009)...nised blue dye test alternative is helping bring...e one step closer for pharma-companies. It is a no...developed by Sepha for use with blister packs an...nd global pharma-companies such as Sanofi-Avenis a...productivity improvements on the packaging line. ...
(Date:11/25/2009)... Biotech firm Replikins Ltd., whic...he 1918 pandemic through the prediction, outbreak,...issued its latest biochemical analysis of the viru...N1 ("Swine Flu") virus has dropped from its peak o...ak in the spring of 2009 to resting non-epidemic l...
(Date:11/25/2009).../PRNewswire/ - Cytochroma today announced the appo...ors. Dr. Moldt will replace Mr. Ulrik Spork as the...he number of Board members remains unchanged at si...eter Moldt to the board and look forward to benefi...a continues to make progress in becoming a leading...
(Date:11/25/2009)...PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (...t, Pharm.D., president and chief executive officer...alth Care Conference. , ,Presentation details are...e Conference,Date: Tuesday, December 1, 2009,...ew York Palace Hotel, New York, NY,Webcast: <a ...
Breaking Biology Technology:Sepha's Blue Dye Test Alternative Brings &#8216;Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings &#8216;Complete Automation' To Pharma-Packaging Quality Assurance 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...ry 27 Debiopharm Group,(Debiopharm), a global ind...focusing on serious medical conditions and particu...of a Debiopharm oncology chair at the Ecole,Polyte...ignal Transduction,in Oncogenesis. Funded through ...chair is to leverage the wide scope of ideas and i...
...rchase Agreement Entered Into Between Genmab, an...DL,s Manufacturing Facility has Rece... Genmab A/S (OMX: GEN),announced today that the p...PDL BioPharma, Inc. under which Genmab would acqui...ved antitrust clearance from the US,antitrust auth...
...es Leading Mobile Computing Workstations with Un... with Patients, COLUMBUS, Ohio, Feb. 26 Artromic...d healthcare technology solutions for the,long-ter...sive referral,agreement with McKesson Automation, ...healthcare services, automation and information te...
Other Biology Technology:Debiopharm and EPFL Establish an Oncology Chair 2Purchase Agreement for Antibody Manufacturing Facility Receives Antitrust Clearance 2Artromick Aligns with McKesson to Enhance Medication Safety at the Patient's Bedside 2Artromick Aligns with McKesson to Enhance Medication Safety at the Patient's Bedside 3
Rabbit Anti-LCAT Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-C Peptide Monoclonal Antibody, Unconjugated, Clone 7E10 from Abcam
Rabbit Anti-Human TAP2 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Anti-Factor XII Light Chain Monoclonal Antibody, Unconjugated from QED Bioscience Inc.
Biology Products: